First Eagle Investment Management’s Journey Medical DERM Stock Holding History

First Eagle Investment Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.31M	Buy	+483,207	New	+$3.37M	0.01%	323

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return

Geneos Wealth Management Englewood, Colorado $5.32B AUM 16.49% 1-Year Est. Return

Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Brighton Jones LLC Seattle, Washington $5.73B AUM 24.99% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

First Eagle Investment Management's DERM Position: Q3 2026 in Review

First Eagle Investment Management opened a new position in Journey Medical (DERM) in Q3 2026: 483,207 shares worth $3.31M. The stake represents 0.01% of the portfolio and ranks #323 among its holdings.

21 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

First Eagle Investment Management held 483,207 shares of Journey Medical worth $3.31M as of Q3 2026.
Journey Medical was a new First Eagle Investment Management position in Q3 2026.
Journey Medical made up 0.01% of First Eagle Investment Management's portfolio in Q3 2026, its #323 holding.
21 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on First Eagle Investment Management's 13F filing for Q3 2026, filed 10 Nov 2026.